azathioprine has been researched along with anthralin in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Baker, H | 1 |
| McDonald, CJ | 1 |
| Lyons, F | 1 |
3 review(s) available for azathioprine and anthralin
| Article | Year |
|---|---|
Psoriasis: a review. II.
Topics: Adrenal Cortex Hormones; Anthralin; Azathioprine; Azauridine; Fluorouracil; Humans; Hydroxyurea; Lomustine; Mechlorethamine; Methotrexate; Psoriasis; Tars; Tretinoin; Ultraviolet Therapy | 1975 |
International Commission for Protection against Environmental Mutagens and Carcinogens. ICPEMC publication no. 6: do treatments available for psoriasis patients carry a genetic or carcinogenic risk?
Topics: Anthralin; Azathioprine; Carcinogens; Coal Tar; Humans; Hydroxyurea; Methotrexate; Mutagenicity Tests; Mutagens; Mutation; Probability; Psoriasis; PUVA Therapy; Risk; Salmonella typhimurium | 1981 |
The uses of systemic chemotherapeutic agents in psoriasis.
Topics: Administration, Topical; Anthralin; Azathioprine; Azauridine; Chemical Phenomena; Chemistry; Humans; Hydroxyurea; Mercaptopurine; Mustard Compounds; Mycophenolic Acid; Psoriasis | 1981 |
3 other study(ies) available for azathioprine and anthralin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Treatment of common skin complaints--changing referral patterns.
Topics: Acne Vulgaris; Anthralin; Azathioprine; Dermatitis, Atopic; Dermatology; Diagnosis, Differential; Eczema; Family Practice; Female; Humans; Ketoconazole; Male; Referral and Consultation; Skin Diseases; Urticaria | 1997 |